Literature DB >> 28209904

Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease.

Catharina H M J Van Elssen1, Mohammad Rashidian2,3, Vladimir Vrbanac4, Kai W Wucherpfennig5,6, Zeina El Habre7, Jana Sticht7, Christian Freund7, Johanne T Jacobsen2,3,8, Juanjo Cragnolini2,3, Jessica Ingram2,3, Loes Plaisier9, Eric Spierings9, Andrew M Tager4,10, Hidde L Ploegh11,3.   

Abstract

The immune system plays a crucial role in many diseases. Activation or suppression of immunity is often related to clinical outcome. Methods to explore the dynamics of immune responses are important to elucidate their role in conditions characterized by inflammation, such as infectious disease, cancer, or autoimmunity. Immuno-PET is a noninvasive method by which disease and immune cell infiltration can be explored simultaneously. Using radiolabeled antibodies or fragments derived from them, it is possible to image disease-specific antigens and immune cell subsets.
Methods: We developed a method to noninvasively image human immune responses in a relevant humanized mouse model. We generated a camelid-derived single-domain antibody specific for human class II major histocompatibility complex products and used it to noninvasively image human immune cell reconstitution in nonobese diabetic severe combined immune deficiency γ-/- mice reconstituted with human fetal thymus, liver, and liver-derived hematopoietic stem cells (BLT mice).
Results: We showed imaging of infiltrating immunocytes in BLT mice that spontaneously developed a graft-versus-host-like condition, characterized by alopecia and blepharitis. In diseased animals, we showed an increased PET signal in the liver, attributable to infiltration of activated class II major histocompatibility complex+ T cells.
Conclusion: Noninvasive imaging of immune infiltration and activation could thus be of importance for diagnosis and evaluation of treatment of graft-versus-host disease and holds promise for other diseases characterized by inflammation.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  GvHD; ImmunoPET; humanized mice; single domain antibodies

Mesh:

Substances:

Year:  2017        PMID: 28209904      PMCID: PMC5450362          DOI: 10.2967/jnumed.116.186007

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  29 in total

Review 1.  Designing the magic bullet? The advancement of immuno-PET into clinical use.

Authors:  Brian D Wright; Suzanne E Lapi
Journal:  J Nucl Med       Date:  2013-08       Impact factor: 10.057

2.  A general strategy for the evolution of bond-forming enzymes using yeast display.

Authors:  Irwin Chen; Brent M Dorr; David R Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-22       Impact factor: 11.205

3.  Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice.

Authors:  Eun Mi Hur; Sonal N Patel; Saki Shimizu; Dinesh S Rao; Priyanthi N P Gnanapragasam; Dong Sung An; Lili Yang; David Baltimore
Journal:  Blood       Date:  2012-10-11       Impact factor: 22.113

4.  An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.

Authors:  Richard Tavaré; Helena Escuin-Ordinas; Stephen Mok; Melissa N McCracken; Kirstin A Zettlitz; Felix B Salazar; Owen N Witte; Antoni Ribas; Anna M Wu
Journal:  Cancer Res       Date:  2015-11-16       Impact factor: 12.701

5.  A general protocol for the generation of Nanobodies for structural biology.

Authors:  Els Pardon; Toon Laeremans; Sarah Triest; Søren G F Rasmussen; Alexandre Wohlkönig; Armin Ruf; Serge Muyldermans; Wim G J Hol; Brian K Kobilka; Jan Steyaert
Journal:  Nat Protoc       Date:  2014-02-27       Impact factor: 13.491

6.  Generation of Immunity against Pathogens via Single-Domain Antibody-Antigen Constructs.

Authors:  Joao N Duarte; Juan J Cragnolini; Lee Kim Swee; Angelina M Bilate; Justin Bader; Jessica R Ingram; Ali Rashidfarrokhi; Tao Fang; Ariën Schiepers; Leo Hanke; Hidde L Ploegh
Journal:  J Immunol       Date:  2016-11-07       Impact factor: 5.422

7.  Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.

Authors:  J Baselga; L Norton; J Albanell; Y M Kim; J Mendelsohn
Journal:  Cancer Res       Date:  1998-07-01       Impact factor: 12.701

8.  HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide.

Authors:  Anne-Kathrin Anders; Melissa J Call; Monika-Sarah E D Schulze; Kevin D Fowler; David A Schubert; Nilufer P Seth; Eric J Sundberg; Kai W Wucherpfennig
Journal:  Nat Immunol       Date:  2010-12-05       Impact factor: 25.606

9.  Noninvasive imaging of immune responses.

Authors:  Mohammad Rashidian; Edmund J Keliher; Angelina M Bilate; Joao N Duarte; Gregory R Wojtkiewicz; Johanne Tracey Jacobsen; Juanjo Cragnolini; Lee Kim Swee; Gabriel D Victora; Ralph Weissleder; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

10.  Graft versus host disease in the bone marrow, liver and thymus humanized mouse model.

Authors:  Matthew B Greenblatt; Vladimir Vrbanac; Vladimir Vbranac; Trevor Tivey; Kelly Tsang; Andrew M Tager; Antonios O Aliprantis
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

View more
  21 in total

Review 1.  Noninvasive PET Imaging of T cells.

Authors:  Weijun Wei; Dawei Jiang; Emily B Ehlerding; Quanyong Luo; Weibo Cai
Journal:  Trends Cancer       Date:  2018-04-17

Review 2.  The Immunoimaging Toolbox.

Authors:  Aaron T Mayer; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2018-05-24       Impact factor: 10.057

Review 3.  Imaging haemopoietic stem cells and microenvironment dynamics through transplantation.

Authors:  Kirsten M Williams; Jennifer Holter Chakrabarty
Journal:  Lancet Haematol       Date:  2020-03       Impact factor: 18.959

4.  Visualization of Activated T Cells by OX40-ImmunoPET as a Strategy for Diagnosis of Acute Graft-versus-Host Disease.

Authors:  Israt S Alam; Federico Simonetta; Lukas Scheller; Aaron T Mayer; Robert Negrin; Sanjiv S Gambhir; Surya Murty; Ophir Vermesh; Tomomi W Nobashi; Juliane K Lohmeyer; Toshihito Hirai; Jeanette Baker; Kenneth H Lau
Journal:  Cancer Res       Date:  2020-09-08       Impact factor: 12.701

5.  ImmunoPET: Concept, Design, and Applications.

Authors:  Weijun Wei; Zachary T Rosenkrans; Jianjun Liu; Gang Huang; Quan-Yong Luo; Weibo Cai
Journal:  Chem Rev       Date:  2020-03-23       Impact factor: 60.622

Review 6.  Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms.

Authors:  Nairo Brilhante-da-Silva; Rosa Maria de Oliveira Sousa; Andrelisse Arruda; Eliza Lima Dos Santos; Anna Carolina Machado Marinho; Rodrigo Guerino Stabeli; Carla Freire Celedonio Fernandes; Soraya Dos Santos Pereira
Journal:  Mol Diagn Ther       Date:  2021-06-19       Impact factor: 4.074

Review 7.  Nanobodies in cancer.

Authors:  Elisha R Verhaar; Andrew W Woodham; Hidde L Ploegh
Journal:  Semin Immunol       Date:  2020-11-30       Impact factor: 11.130

Review 8.  Nanobodies for Medical Imaging: About Ready for Prime Time?

Authors:  Léa Berland; Lauren Kim; Omar Abousaway; Andrea Mines; Shruti Mishra; Louise Clark; Paul Hofman; Mohammad Rashidian
Journal:  Biomolecules       Date:  2021-04-26

9.  Induction of antigen-specific tolerance by nanobody-antigen adducts that target class-II major histocompatibility complexes.

Authors:  Thibault Harmand; Liyan Y Smeding; Novalia Pishesha; Weiyi Ma; Leif S Ludwig; Robine Janssen; Ashraful Islam; Yushu J Xie; Tao Fang; Nicholas McCaul; William Pinney; Harun R Sugito; Martin A Rossotti; Gualberto Gonzalez-Sapienza; Hidde L Ploegh
Journal:  Nat Biomed Eng       Date:  2021-06-14       Impact factor: 25.671

Review 10.  Predictive Markers of Immunogenicity and Efficacy for Human Vaccines.

Authors:  Matthieu Van Tilbeurgh; Katia Lemdani; Anne-Sophie Beignon; Catherine Chapon; Nicolas Tchitchek; Lina Cheraitia; Ernesto Marcos Lopez; Quentin Pascal; Roger Le Grand; Pauline Maisonnasse; Caroline Manet
Journal:  Vaccines (Basel)       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.